Episode Details

In this episode of Global Economic Press, Alex Brady discusses the recent expansion of FitRx's online weight-management program, which now includes a needle-free oral semaglutide option. This development provides an alternative for patients who are hesitant about injectable treatments. The program offers a comprehensive approach to weight management, combining online medical assessments, provider reviews, ongoing clinical support, and pharmacy delivery through a single virtual platform. FitRx continues to offer additional weight-management pathways, including injectable treatment options and assistance with insurance coverage for certain Food and Drug Administration-approved medications when clinically appropriate.

The expanded FitRx program includes services such as personalized weight-management plans, prescription and refill management, secure messaging with the care team, and ongoing medical supervision. Patients can also explore alternative treatment pathways, including compounded injectable semaglutide and tirzepatide, as well as non-GLP-1 prescription options. Pricing and availability vary by state, and the program emphasizes the importance of medical oversight and patient safety. For more information about FitRx and its services, visit FitRx's website.